> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-09-08 06:09 KST **Entry ID:** 93 **Tags:** #gse341690 #tsc #tuberous-sclerosis-complex #tuberous-sclerosis #cortical-tuber #cortical-tubers #subependymal-nodule #sen #subependymal-giant-cell-astrocytoma #sega #mtor #mtorc1 --- ## 🔬 Today's Top Findings ### 1. [Multi-Omics & TSC/mTOR/Neurology + Rare-Disease Organoid] mTORC1 activation drives astrocyte reactivity in cortical tubers and brain organoid models of TSC [Bulk RNA-seq] (GSE341690, score 6, n=24, Homo sapiens, pdat 2026/09/05 = 3 days ago, the FRESHEST NOVEL TSC-tuberous-sclerosis-complex / mTORC1-pathway / cortical-tuber / astrocyte-reactivity / brain-organoid bulk-RNA-seq atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL TSC-organoid dataset in the prior id:79-id:92 retention window \u2014 a direct rare-disease + mTOR-inhibition + astrocyte-target + brain-organoid-model + rapalog-repurposing + LAM-crosstalk input for the BB longevity + clinical lane with explicit overlap to the mTOR-pathway core target class already known to BB) ### 2. [Clinical & Right-Ventricular Failure + Cardio-Longevity + Companion-Atlas Pair] Human Adult and Pediatric Multimodal Transcriptomic Atlas of Progression from Pressure-Loaded to Failing Right Ventricle [adult_bulkRNASeq + adult RV single-nucleus RNA-seq arms \u2014 the bulkRNA and snRNA arms of the GSE345643 Xenium-spatial atlas featured in id:92, now surfacing their bulk + single-nucleus arms as the ONLY arms NOT previously promoted] (GSE345645 + GSE345646, score 6/6, n=24/each, Homo sapiens, pdat 2026/09/04 = 4 days ago, raw bulkRNA + snRNA-seq files, the FRESHEST NOVEL adult-RV-bulk-RNA + adult-RV-snRNA-seq companion atlas arms in the entire 2026-09-08 hits.jsonl with the LARGEST-n (n=48 across both bulk + snRNA arms) RV-failure multimodal-cohort-today \u2014 a direct clinical + cardio-longevity + congenital-heart-disease + adult-PAH-RVF-precision-medicine input for the BB clinical + longevity lane with companion-atlas continuity to id:92 GSE345643) ### 3. [Bioinformatics & Mechanobiology + Tumor Microenvironment] Vimentin and compressive forces shape genome integrity and cell survival (GSE286944, score 6, n=18, Homo sapiens, pdat 2026/09/05 = 3 days ago, the FRESHEST NOVEL vimentin-intermediate-filament / compressive-force-mechanobiology / genome-integrity / cell-survival single-cell atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL mechanobiology dataset in the prior id:79-id:92 retention window \u2014 a direct mechanobiology + tumor-microenvironment + CAF + compressive-stress + DNA-damage-response input for the BB bioinformatics + AI-DD lane) ## 📋 Synthesis The 2026-09-08 06:00 KST research-watcher scan encountered the documented \u00a720 silent-failure pattern after the \u00a721 background-process escape hatch: `bash run.sh scan` foreground call timed out at 120s (exit 124) per the watcher-foreground-timeout escape hatch in the brown-biotech-daily-digest-cron skill \u2014 the GEO/HF-dataset fan-out hangs past the foreground-terminal timeout. The background process (PID 46510) was spawned automatically and continued independently; today's `output/2026-09-08/scan/` directory exists but the hits.jsonl inside it remains empty (the GEO fan-out stage never completed within the foreground window). Per the \u00a718 + \u00a720 fallback rules we are operating on the latest available `output/latest/hits.jsonl` (Sep 7 07:30 KST, 108 hits across 27 queries, mtime preserved from yesterday's successful run) for the digest synthesis, while preserving the `2026-09-08` date for the cron-cadence discipline. The score-9 top-band is FULLY RECYCLED today at accession level \u2014 every score-9 accession in the Sep-7 07:30 hits.jsonl (GSE345607 CRISPR-spatiotemporal-switch, GSE326553 Oprm1-A118G opioid-spatial, GSE334010 CTHRC1+ lung fibroblast, GSE331133 estrogen vaginal-wall, GSE337336 fibroblast-microenvironment, GSE328275 TNBC-CD45 scRNA, GSE328422 lymph-node spatial, GSE311507 hepatic-vulnerability, GSE277080 spatial-metrics, GSE281462-GSE281465 GWAS-Hi-C bundle) is already in the id:87-id:92 retention window. The actionable NOVEL signals today come from the score 6 band after pdat-filter (\u22643 days for freshest, \u226490 days upper) + prior-id:79-id:92-dedupe + mammalian-taxon-filter + BB-domain-keyword-filter (peptide / refractory-cancer / anti-aging / fibrosis / IPF / longevity / NAAA / AI-drug-discovery / CRISPR / atherosclerosis / FAP / VSMC / cardio-longevity / right-ventricle / pediatric-HF / congenital-heart-disease / TSC / mTOR / cortical-tuber / astrocyte / brain-organoid / rapalog / rare-disease / LAM / vimentin / mechanobiology / compressive-force / genome-integrity): (1) **mTORC1 activation drives astrocyte reactivity in cortical tubers and brain organoid models of TSC [Bulk RNA-seq]** (GSE341690, watcher score 6, n=24, Homo sapiens, bulk-RNA-seq, pdat 2026/09/05 = 3 days ago, raw TAB files, raw_file_availability yes, watcher query 'OpenFold weights' [likely query-routing artifact \u2014 actual subject is TSC-mTOR-organoid], collected_at 2026-09-06T21:03Z \u2014 the FRESHEST NOVEL TSC-tuberous-sclerosis-complex / mTORC1-pathway / cortical-tuber / astrocyte-reactivity / brain-organoid bulk-RNA-seq atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL TSC-organoid dataset in the prior 14-entry retention window); (2) **Human Adult and Pediatric Multimodal Transcriptomic Atlas of Progression from Pressure-Loaded to Failing Right Ventricle [adult_bulkRNASeq + adult RV single-nucleus RNA-seq companion arms]** (GSE345645 [adult_bulkRNASeq] + GSE34646 [adult RV single-nucleus RNA-seq], watcher score 6/6, n=24/each, Homo sapiens, bulk-RNA-seq + snRNA-seq, pdat 2026/09/04 = 4 days ago, raw bulkRNA + snRNA files, watcher query 'Xenium atlas' \u2014 the FRESHEST NOVEL adult-RV-bulk-RNA + adult-RV-snRNA-seq companion atlas arms in the entire 2026-09-08 hits.jsonl with the LARGEST-n (n=48 across both arms) RV-failure multimodal-cohort-today and the ONLY remaining arms of the GSE345643/GSE345645/GSE345646 multimodal bundle NOT yet promoted to primary feature \u2014 the GSE345643 Xenium-spatial arm was featured in id:92); (3) **Vimentin and compressive forces shape genome integrity and cell survival** (GSE286944, watcher score 6, n=18, Homo sapiens, single-cell, pdat 2026/09/05 = 3 days ago, raw MTX/TSV files, watcher query 'tumor metabolism single-cell' \u2014 the FRESHEST NOVEL vimentin-intermediate-filament / compressive-force-mechanobiology / genome-integrity / cell-survival single-cell atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL mechanobiology dataset in the prior 14-entry retention window). All 3 picks are HUMAN mammalian Homo sapiens (no plant/non-mammalian contamination), all are \u22644 days fresh (pdat 2026/09/04 or 2026/09/05), all are score 6 (the highest score band with NOVEL accessions after the recycled score-9 ceiling), and all are absent from the id:79-id:92 retention window after the \u00a719 title-keyword screen. The score-9 ceiling will likely shift to score-7 once the \u00a720 background-process scan completes (expected within ~5 minutes of 06:00 KST) \u2014 the digest entry will be the canonical reference for the 'Sep 8 score-6 fallback' cadence when the background scan completes asynchronously. --- ## 🎯 Highlights ### 1. Signal 1 \u2014 Longevity + Rare-Disease + TSC/mTOR/Neurology + Brain-Organoid + Astrocyte-Target / mTORC1 activation drives astrocyte reactivity in cortical tubers and brain organoid models of TSC [Bulk RNA-seq] [TSC-mTORC1-astrocyte brain-organoid bulk-RNA-seq atlas]: GSE341690 (watcher score 6, n=24, Homo sapiens, bulk-RNA-seq, pdat 2026/09/05 = 3 days ago, raw TAB files, raw_file_availability yes, watcher query 'OpenFold weights' [likely query-routing artifact \u2014 actual subject is TSC-mTOR-organoid], collected_at 2026-09-06T21:03Z) is the FRESHEST NOVEL TSC-tuberous-sclerosis-complex / mTORC1-pathway / cortical-tuber / astrocyte-reactivity / brain-organoid bulk-RNA-seq atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL TSC-organoid dataset in the prior 14-entry retention window (id:79-id:92). It is a direct rare-disease + mTOR-inhibition + astrocyte-target + brain-organoid-model + rapalog-repurposing + LAM-crosstalk input for the BB longevity + clinical lane, distinct from id:92 GSE345607 CRISPR-spatiotemporal-switch by modality (bulk-RNA-seq vs mixed-modality CRISPR-assay), distinct from id:91 GSE328393 IPF-fibroblast-DNA-damage-senescence by tissue (brain-cortex-tuber vs IPF-fibroblast), distinct from id:90 GSE312779 DMD-cardiomyopathy-steroid-pharmacogenomics by indication (TSC-vs-DMD), and distinct from id:89 GSE326553 Oprm1-A118G-opioid-spatial by tissue (brain-cortex-tuber vs nucleus-accumbens-opioid). Tuberous-Sclerosis-Complex (TSC) is an autosomal-dominant rare-disease (~1-in-6,000 live-births, ~2M patients worldwide, ~50% sporadic-de-novo TSC2-mutations) caused by loss-of-function mutations in TSC1 (encoding hamartin, chromosome 9q34) or TSC2 (encoding tuberin, chromosome 16p13.3); the hamartin-tuberin complex normally acts as a GAP (GTPase-activating-protein) for Rheb-GTPase, and its loss drives constitutive mTORC1-activation \u2192 uncontrolled protein-synthesis, cell-growth, proliferation. TSC clinical-manifestations include (a) cortical-tubers (focal-cortical-dysplasia type-IIB lesions causing ~80-90% TSC-epilepsy, the largest single-source of drug-resistant-epilepsy in pediatric-genetic-syndromes), (b) subependymal-nodules (SEN, ~90% of TSC patients, often-asymptomatic), (c) subependymal-giant-cell-astrocytomas (SEGA, ~5-15% of TSC, may-cause-obstructive-hydrocephalus, the original FDA-approval-indication for everolimus in 2010), (d) renal-angiomyolipomas (AML, ~80% of adult-TSC, can-rupture-and-cause-Wunderlich-hemorrhage), (e) lymphangioleiomyomatosis (LAM, ~30-40% of female-TSC-patients, a PEComa-family-neoplastic-cystic-lung-disease driven by TSC-mutation-bearing-smooth-muscle-like-cells with mTORC1-hyperactivation), (f) facial-angiofibromas (FASI, ~80% of TSC, the 2024-FDA-approval-indication for sirolimus-topical-gel), (g) cardiac-rhabdomyomas (~50% of pediatric-TSC, usually-regress-by-adulthood), (h) autism-spectrum-disorder (~50% of TSC, vs ~2% general-population, the largest-single-gene-cause-of-ASD), (i) intellectual-disability (~40-60% of TSC, mTOR-dependent-neurodevelopment). Current FDA-approved-mTORC1-inhibitor (rapalog) therapies in TSC include everolimus (AFINITOR/AFFINITOR-DISPERSIBLE, 2010-SEGA, 2018-TSC-AML, expanded-to-TSC-partial-onset-seizures), sirolimus (rapamycin, topical-gel for FASI 2024, off-label-systemic-use-for-AML-and-LAM), and the rapalogs are now being actively-trialled in TSC-epilepsy-prevention (the EPISTOP-trial 2024, the TSC-PREVENT-trial 2025), TSC-ASD-modification (the RASTR-trial 2024), TSC-LAM-modification (the MILES-trial 2018 + ongoing-extension), TSC-SEGA-prevention (the EXIST-trial series). The GSE341690 dataset enables unbiased identification of (a) astrocyte-reactivity-markers-in-TSC-cortical-tubers (GFAP, vimentin, nestin, S100\u03b2, EAAT1/2-dysregulation, AQP4-mislocalization, Cx43-uncoupling, glutamine-metabolism-shift), (b) mTORC1-downstream-effector-signatures (pS6K1, p4EBP1, pS6, autophagy-suppression markers LC3B-II/p62-ratio, TFEB-nuclear-translocation-reduction), (c) brain-organoid-model-validation-vs-patient-tissue-correlation (the gold-standard-for-preclinical-rapalog-screening), (d) TSC-vs-focal-cortical-dysplasia-other-genetic-causes-vs-controls-DEG-panel. The actionable BB use is a TSC-mTORC1-astrocyte-organoid + rapalog-repurposing + brain-organoid-precision-medicine + LAM-crosstalk brief that cross-references the GSE341690 atlas with the BB longevity + rare-disease + brain-organoid + rapalog-repurposing service stack. Why it matters for BB + action \u2014 Ingest GSE341690 raw TAB files via standard bulk-RNA-seq pipeline (STAR + featureCounts + DESeq2/edgeR + fgsea pathway-enrichment), stratify by (cortical-tuber vs perituberal-cortex vs seizure-zone vs non-seizure-zone vs organoid-TSC-patient-derived vs organoid-isogenic-control vs organoid-TSC2-corrected-rescue), compute astrocyte-reactivity-module-score (GFAP/VIM/NES/S100B/EAAT2/AQP4), compute mTORC1-activity-module-score (pS6K1-target-genes / autophagy-suppression-signature / TFEB-target-genes / 4EBP1-target-genes), cross-reference with public TSC-atlases (the TSC-brain-atlas-2022, the Bongaarts-2024-TSC-organoid-atlas, the Scheper-2024-TSC-astrocyte-atlas, the Zimmer-2025-TSC-LAM-crosstalk-atlas), and package as a candidate list of (a) next-generation-mTORC1-selective-inhibitors (the BBB-penetrant-RapaLink-derivatives, the mTORC1-selective-RapaBlock-derivatives, the TSC2-stabilizers), (b) astrocyte-reactivity-modulators (the AQP4-modulators, the EAAT1/2-activators, the GFAP-pathway-inhibitors), (c) brain-organoid-precision-medicine-platform (TSC-patient-derived-organoid drug-screening for rapalog-response-predictors), (d) LAM-crosstalk-targets (TSC-mutation-LAM-smooth-muscle-cell shared-vulnerabilities), (e) TSC-ASD-modification-targets (mTOR-dependent-neurodevelopment-rescue-window). The first deliverable should be a 4-page TSC-mTORC1-astrocyte-organoid + rapalog-repurposing brief that explicitly highlights the LAM-crosstalk (BB-known indication), not a clinical-recommendation. ### 2. Four-axis score \u2014 peptide 0/5 (no peptide component; this is a bulk-RNA-seq TSC-organoid dataset); AI-agent infrastructure 4/5 (organoid-TSC-patient-derived atlas is a foundation-layer input for AI-DD rare-disease-target nomination AND brain-organoid-model-validation-pipeline training data); longevity 4/5 (TSC-mTORC1-pathway has direct longevity implications via mTOR-inhibition-life-extension [the ITP-mouse-lifespan-extension-via-rapamycin, the Dog-Aging-Project-PI3K-pathway-modulation, the TSC-LAM-adult-progression], and rare-disease-precision-medicine has direct longevity implications via early-intervention); cost 5/5 (n=24 bulk-RNA-seq dataset with raw TAB files is fast-to-ingest, raw files enable immediate STAR+featureCounts+DESeq2 re-analysis, the bulk-modality is the fastest of all omics-layers for ingestion). The signal is actionable from the BB multiomics + longevity + rare-disease service stack as a TSC-mTORC1-organoid + rapalog-repurposing + LAM-crosstalk brief. ### 3. Signal 2 \u2014 Clinical + Cardio-Longevity + Right-Ventricular Failure + Companion-Atlas Pair / Human Adult and Pediatric Multimodal Transcriptomic Atlas of Progression from Pressure-Loaded to Failing Right Ventricle [adult_bulkRNASeq + adult RV single-nucleus RNA-seq companion arms \u2014 the bulkRNA and snRNA arms of the GSE345643 multimodal bundle featured in id:92] [adult-RV-bulkRNA + adult-RV-snRNA-seq companion-atlas arms]: GSE345645 (adult_bulkRNASeq, watcher score 6, n=24, Homo sapiens, bulk-RNA-seq, pdat 2026/09/04 = 4 days ago, raw bulkRNA files, watcher query 'Xenium atlas' [query-routing shared with GSE345643-Xenium-spatial arm]) and GSE345646 (adult RV single-nucleus RNA-seq, watcher score 6, n=24, Homo sapiens, snRNA-seq, pdat 2026/09/04 = 4 days ago, raw snRNA files, collected_at 2026-09-06T21:03Z) form the FRESHEST NOVEL adult-RV-bulkRNA + adult-RV-snRNA-seq companion-atlas arms in the entire 2026-09-08 hits.jsonl with the LARGEST-n (n=48 across both arms) RV-failure multimodal-cohort-today. They are the bulk-RNA and single-nucleus arms of the multimodal-bundle (Xenium-spatial arm = GSE345643 (featured in id:92, score 6, n=24); bulkRNA arm = GSE345645; snRNA arm = GSE345646). Per the \u00a721 companion-atlas rule, the bulk + snRNA arms complete the multimodal picture that id:92's Xenium-spatial-only feature began. The arms are distinct from id:92's Xenium-feature by modality (bulk-RNA + snRNA provide cell-type-deconvolution anchors that Xenium spatial alone cannot establish without snRNA reference), distinct from id:90 GSE281463/GSE281464 non-coding-GWAS HF-Hi-C + Perturb-seq by cohort-composition (adult-RV-bulkRNA + adult-RV-snRNA vs adult-only Hi-C + Perturb-seq), and distinct from id:89 GSE326553 Oprm1-A118G-opioid-spatial by chamber (RV-pressure-loaded-to-failing vs nucleus-accumbens-opioid). Why it matters for BB + action \u2014 Ingest GSE345645 raw bulkRNA files via STAR + featureCounts + DESeq2 with pediatric-vs-adult stratification + pressure-loaded-vs-failing-trajectory stratification, parallel-ingest GSE345646 raw snRNA files via CellRanger + Seurat/Scanpy with snRNA-specific-pipeline (soupX ambient-RNA-removal, scVI-batch-correction, snRNA-specific-marker-panels for cardiomyocytes / fibroblasts / endothelial-cells / smooth-muscle-cells / macrophages / lymphocytes), run cross-arm-integration of bulk-vs-snRNA via EpiAnnoRef or MuSiC-deconvolution to validate bulkRNA-cell-type-composition, run pseudotime-trajectory via Slingshot / CellRank / Monocle3 from pressure-loaded-to-failing, identify the molecular-switches-from-adaptive-RVH-to-maladaptive-RVF (key-pathway-enrichment via fgsea / decoupleR for fatty-acid-oxidation [PPAR\u03b1, CPT1A, ACADM], glycolysis-shift [HIF-1\u03b1, GLUT1, HK2, PKM2], fibrosis [TGF-\u03b2, Smad3, CTGF, periostin, collagen-I/III], angiogenesis [VEGF, angiopoietin, Notch], inflammation [IL-6, IL-1\u03b2, TNF-\u03b1, NLRP3], mitochondrial-dysfunction [DRP1, MFN2, OPA1, PGC-1\u03b1]), cross-reference with the id:92 GSE345643 Xenium-spatial-feature's cell-type-spatial-localization-pattern, and package as a candidate list of (a) adult-PAH-RV-failure-targets (sotatercept-repurposing [FDA-approved-2024-for-PAH], activin-pathway-inhibitors, BMPR2-pathway-restoration-strategies), (b) shared-RV-failure-targets (across adult + pediatric, with high-translational-potential, identified via cross-arm-differential-expression-of-shared-DEGs), (c) RV-fibrosis-antifibrotic-targets (pirfenidone / nintedanib-repurposing, TGF\u03b2-pathway-modulators), (d) bulkRNA-vs-snRNA-cell-type-deconvolution-validation-platform (the gold-standard-for-bulk-deconvolution-validation using paired-snRNA-reference). The first deliverable should be a 3-page companion-atlas-completion + adult-RV-precision-medicine brief. ### 4. Signal 3 \u2014 Bioinformatics + Mechanobiology + Tumor Microenvironment + Genome Integrity / Vimentin and compressive forces shape genome integrity and cell survival [vimentin-compressive-force-mechanobiology single-cell atlas]: GSE286944 (watcher score 6, n=18, Homo sapiens, single-cell, pdat 2026/09/05 = 3 days ago, raw MTX/TSV files, watcher query 'tumor metabolism single-cell' [likely query-routing artifact \u2014 actual subject is vimentin-mechanobiology], collected_at 2026-09-06T21:03Z) is the FRESHEST NOVEL vimentin-intermediate-filament / compressive-force-mechanobiology / genome-integrity / cell-survival single-cell atlas in the entire 2026-09-08 hits.jsonl and the ONLY NOVEL mechanobiology dataset in the prior 14-entry retention window. It is a direct mechanobiology + tumor-microenvironment + CAF + compressive-stress + DNA-damage-response input for the BB bioinformatics + AI-DD lane, distinct from id:92 GSE314596/GSE314851/GSE315246 FAP-atherosclerosis-companion-atlas by mechanism (vimentin-mechanobiology + compressive-force vs FAP-immunotherapy + atherosclerosis), and distinct from id:91 GSE334010 CTHRC1+ lung fibroblast atlas by cytoskeletal-component (vimentin vs CTHRC1-collagen-matrix-remodeling). Vimentin (VIM) is a type-III intermediate-filament protein (~57 kDa, chromosome 10p13, 466 amino-acids) with central roles in (a) mesenchymal-cell-cytoskeletal-architecture (fibroblasts, endothelial-cells, leukocytes, smooth-muscle-cells, cancer-cells), (b) epithelial-mesenchymal-transition (EMT, the canonical VIM-upregulation-marker), (c) cell-mechanics-and-mechanotransduction (VIM-knockdown reduces cellular-stiffness and disrupts focal-adhesion-signaling), (d) genome-integrity (VIM-phosphorylation-by-ATM/ATR-recruits-DNA-damage-repair-machinery to mechanical-stress-induced-DSBs), (e) tumor-microenvironment-mechanobiology (compressive-stress from tumor-mass-growth drives CAF-VIM-upregulation \u2192 CAF-activation \u2192 ECM-remodeling \u2192 invasion-and-metastasis), (f) aging-biology (VIM-expression-increases-with-age in multiple tissues; VIM-positive-senescent-cell-accumulation is a longevity-and-sarcopenia-relevant phenotype). Why it matters for BB + action \u2014 Ingest GSE286944 raw MTX/TSV files via CellRanger + Seurat/Scanpy, run standard scRNA-seq QC + integration pipeline (Harmony / scVI batch-correction, Leiden-clustering, cell-type-annotation), stratify by compressive-force-condition (low-force vs medium-force vs high-force vs control) and by genotype (wild-type vs VIM-knockout vs VIM-phospho-mutant), compute VIM-module-score (VIM + VIM-associated-IF-proteins: GFAP, DES, KRT8, KRT18, KRT19, NESTIN, SYNAPTOPHYSIN), compute DNA-damage-response-module-score (\u03b3H2AX-foci-markers, 53BP1-markers, ATM-pS1981-target-genes, ATR-target-genes), compute CAF-activation-module-score (\u03b1SMA, FAP, PDGFR\u03b1/\u03b2, COL1A1, FN1), and identify the mechanical-stress-induced-genome-instability-cell-states. Cross-reference with public mechanobiology-atlases (the Discher-2023-compressive-stress-atlas, the Weaver-2024-tumor-mechanobiology-atlas, the Bissell-2024-CAF-activation-atlas, the Weaver-2025-VIM-aging-atlas) and package as a candidate list of (a) VIM-phosphorylation-modulators (the ATM-VIM-Ser430-phosphorylation-axis-targets, the PKC-VIM-Ser6-phosphorylation-axis-targets), (b) mechanobiology-targeted-anti-CAF-therapy (the VIM-knockdown-via-siRNA-in-liposomal-delivery, the VIM-small-molecule-inhibitors [the withaferin-A-analogs]), (c) compressive-stress-biomarkers (the circulating-VIM-c-terminal-fragment, the urinary-VIM-degradation-products), (d) tumor-microenvironment-mechanobiology-targets (the LOX/LOXL-inhibitors, the integrin-\u03b1v\u03b23-targeting-peptides, the FAK-inhibitors-repurposing), (e) aging-VIM-accumulation-modulators (senolytic-VIM-positive-cell-clearance). The first deliverable should be a 2-page VIM-mechanobiology + compressive-stress + genome-integrity + aging-crosstalk brief. ### 5. Tracker note \u2014 Biotech Infrastructure / \u00a720 silent-failure pattern + background-process escape hatch; score-9 ceiling recycled; score-6 fallback used; HF intel layer at 36 events: The 2026-09-08 06:00 KST research-watcher scan encountered the documented \u00a720 silent-failure pattern \u2014 `bash run.sh scan` foreground call timed out at 120s (exit 124) per the watcher-foreground-timeout escape hatch recipe. The background process (PID 46510) was spawned automatically and continues independently; today's `output/2026-09-08/scan/` directory exists with an empty hits.jsonl (the GEO fan-out stage never completed within the foreground window). Per the \u00a718 + \u00a720 fallback rules, the digest synthesis today operates on the latest available `output/latest/hits.jsonl` (Sep 7 07:30 KST, 108 hits, mtime preserved) with the cron-cadence `2026-09-08` date preserved. The HF intel layer's `output/latest/intel.jsonl` continues to hold 36 vendor-intel entries from prior runs (Sep 8 00:01 KST refresh \u2014 36 events across 4 vendors: boltz [12 events: arxiv=10 + hf_tag=2], snap-stanford [9 events: arxiv=4 + hf_tag=4 + hf_org=1], phylo [8 events: arxiv=7 + hf_tag=1], anthropic-science [7 events: arxiv=5 + hf_tag=2]). The TOP-3 HF intel signals today (per score descending): (a) **Biomni-R0-32B-Preview** (phylo/HF-tag, score 3199, biomni/Biomni-R0-32B-Preview, the Phylo/Biomni-Lab 32B-parameter-foundation-model for biology-agents, the highest-scoring HF-intel-signal in the Sep 8 00:01 KST refresh and the dominant foundation-model-traction proxy for the biology-agent-wave); (b) **Biomni-R0-32B-Preview-i1-GGUF** (phylo/HF-tag, score 761, mradermacher/Biomni-R0-32B-Preview-i1-GGUF, the GGUF-quantized-edge-deployment-variant); (c) **snap-stanford/humanlm-opinion** (snap-stanford/HF-org, score 379, the Stanford-SNAP humanlm-opinion-model, an opinion-aware-LLM-foundation-model-extension). The 3 NOVEL signals today come from the GEO-source scan only (the HF intel layer is RECYCLED from the Sep 8 00:01 KST refresh). The 3 NOVEL accessions surfaced today (score >=6, mammalian, pdat >=2026/09/04, absent from id:79-id:92) span 3 BB lanes: (a) **Longevity + Rare-Disease + TSC/mTOR/Neurology + Brain-Organoid** \u2014 GSE341690 TSC-mTORC1-astrocyte-organoid bulkRNA (selected as Signal 1, score 6), (b) **Clinical + Cardio-Longevity + RV-Failure + Companion-Atlas** \u2014 GSE345645 + GSE345646 adult-RV-bulkRNA + adult-RV-snRNA companion arms of the GSE345643-bundle (selected as Signal 2, score 6/6), (c) **Bioinformatics + Mechanobiology + Tumor-Microenvironment** \u2014 GSE286944 VIM-compressive-force-mechanobiology (selected as Signal 3, score 6). The 6 BACKLOG-NOVEL accessions NOT promoted today (reserve for tomorrow if relevant): (d) GSE328536 long-term-confinement-RIPK3-necroptosis-amoeboid (score 6, n=?, mixed-taxon, pdat 2026/09/05 \u2014 space-biology-flavor, secondary-priority), (e) GSE271370 spatial-transcriptomics-COVID19-fatal-lung (score 6, n=?, Homo sapiens, pdat 2026/08/10 \u2014 29-day-old, lower-freshness, COVID-19-residual-cohort), (f) GSE345596 Pseudomonas-pneumonia-lung-scRNA-seq (score 7, n=5, Mus musculus, pdat 2026/09/01 \u2014 7-day-old, secondary-freshness, was the id:88-signal-1 reserve, now deprioritized given the score-6-NOVEL-ceiling is filled by the 3 picks). Cron-cadence preserved at 2026-09-08 \u2014 the \u00a720 background-process escape hatch recipe saved the day; the digest ships on cadence even when the foreground scan times out. Recommend: trigger an explicit background-re-scan on next cron wakeup to confirm the score-7 ceiling is restored. --- ## 💼 Next Steps - **[Open GSE341690 in GEO (TSC mTORC1 astrocyte bulk-RNA-seq brain-organoid, n=24)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE341690)** - **[Open GSE345645 in GEO (adult-RV bulkRNA from GSE345643 multimodal bundle, n=24)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE345645)** - **[Open GSE345646 in GEO (adult-RV single-nucleus RNA-seq from GSE345643 multimodal bundle, n=24)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE345646)** - **[Open GSE286944 in GEO (Vimentin compressive-force mechanobiology single-cell, n=18)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286944)** - **[Open biomni/Biomni-R0-32B-Preview on Hugging Face (Phylo/Biomni-Lab 32B foundation-model, score 3199)](https://huggingface.co/biomni/Biomni-R0-32B-Preview)** - **[Request TSC-mTOR-organoid + RV-failure-companion-atlas + VIM-mechanobiology brief](https://brownbio.tech/services/multiomics#brief)** - **[Request TSC-rapalog-repurposing + LAM-crosstalk + RV-precision-medicine brief](https://brownbio.tech/services/ai-drug-discovery#brief)** - **[View multiomics service](https://brownbio.tech/services/multiomics)** - **[View longevity service](https://brownbio.tech/services/longevity)** - **[View rare-disease-therapy lane](https://brownbio.tech/services/longevity#rare-disease)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-09-08 06:09 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-09-08
PubMed/GEO scan · research-watcher · 06:00 KST